Skip to Content
Søg Menu

Jennifer Spillane

Efgartigimod is Safe and Effective in Previously Refractory AChR Myasthenia Gravis Patients

/ Jennifer Spillane
EAN24Myasthenia Gravis Play the Video 2:32
Nils Erik Gilhus

Presidential Symposium: Norwegian Professor Nils Erik Gilhus Giving a Named Lecture on Myasthenia Gravis

/ Nils Erik Gilhus
EAN24Myasthenia Gravis Play the Video 3:50
Ângela Mesquita

Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes

/ Ângela Sofia Gerós Mesquita
EHA24 Play the Video 01:39
Miia Kivipelto

The Meaningful Benefits for Patients with Alzheimer’s Disease

/ Miia Kivipelto
AlzheimerEAN24 Play the Video 2:34
Jenny Linnea Victoria Lindroos

Women with Myasthenia Gravis are Twice as Likely to Have a Planned Casarean Section

/ Jenny Linnea Victoria Lindroos
EAN24Myasthenia Gravis Play the Video 3:02
Astri Arnesen

Disease-Specific Patient Journeys for Huntington's Disease

/ Astri Arnesen
EAN24 Play the Video 1:05

EAN24: Efgartigimod in Generalized Myasthenia Gravis Are Well Tolerated and Efficacious

/ Jan Andreasen
EAN24Myasthenia Gravis

Internetbaseret terapi – kan man gå til psykolog hjemmefra?

/ Nikita Marie Sørensen / Johanne Jeppesen Lomholt
PsykiatriAngst
Lutz Frölich

Alzheimer's Disease – Clinical Implementation of New Anti-Amyloid Treatment

/ Lutz Frölich
AlzheimerEAN24 Play the Video 02:08
Elena Cortés Vicente

Myasthenia­ Gravis: Cyclic­ and­ Continuous­ Dosing­ of ­Intravenous­ Efgartigimod

/ Elena Cortés Vicente
EAN24Myasthenia Gravis Play the Video 02:10
Back to top